Response to Graffelman: Tests of Hardy-Weinberg Equilibrium
To the Editor: Testing for Hardy-Weinberg equilibrium (HWE) is perhaps the most common quality-control procedure in all of human genetics. Although there are many potential explanations for departures from HWE, the prototypical causes of departure from HWE are genotyping error and differential missing-data rates among genotypes. 1 These two are critically important because they can give rise to false positives in genetic association studies. 2 Standard practice in association studies is to test for HWE in all samples (or control samples) and to reject any marker with a p value for HWE < a. Wigginton et al. note that with exact probabilities in hand, there are four possible tests of HWE. Specifically, they outline two one-tailed tests (P low , P high ) and two two-tailed tests (P HWE , P 2a ). They define P HWE as the probability of observing a genotype configuration at least as unlikely as that actually observed and P 2a as min(1.0, 2P high , 2P low ). Wigginton et al. recommend that P HWE should be used in almost all circumstances and discard P 2a as too conservative (i.e., as producing incorrect probability values).
P DOST ¼ min(2P high , 2P low ), the statistic proposed by Graffelman, is just an imperfect approximation of P 2a . P DOST often takes values > 1.0 and still produces incorrect p values whenever allele frequencies are unequal. If we denote P DOST (x) as the value of P DOST associated with sample-configuration x, we can guarantee that, under the null hypothesis of HWE, P(P DOST % P DOST (x)) < P DOST (x) whenever allele frequencies are unequal. In contrast, using P HWE , P low , P high guarantees a properly calibrated test statistic so that, for example, P(P HWE % P HWE (x)) ¼ P HWE (x), regardless of allele frequency.
A simple example is illustrative. Consider a sample of 100 individuals in whom two copies of the rare allele are present. Two configurations are possible, one with two heterozygotes and another with a single rare allele homozygote. The first configuration has probability of 198/199, and the second has a probability of 1/199 Sheridan and colleagues sequenced TUBA8 and found a 14 bp deletion in intron 1 that affects splicing. They provide further evidence that TUBA8 is involved in the disease state by analyzing its expression in the developing mouse brain by in situ hybridization. They report that Tuba8 is widely expressed in developing neural structures, with strongest expression in the cortical plate at E15.5 and E18.5 and in the cortical plate, subplate, and hippocampus at P0.
A meaningful analysis of individual tubulin gene expression by in situ hybridization requires the use of probes that avoid cross-hybridization among the highly conserved coding regions, relying exclusively on either the variant 5 0 or 3 0 untranslated regions. The probe employed by Sheridan and colleagues was 443 nucleotides in length, of which 415 correspond to sequences contained within the conserved coding region. Consequently, this probe shares a very high sequence homology with other a-tubulins. 4 An Ensembl BLAST search with the Sheridan probe against total mouse cDNA results in six other hits, each being at least 300 nucleotides in length with at least 80% sequence identity. Each of these hits corresponds to one of the six other members of the a-tubulin family and includes a 374 nucleotide stretch that shares 84.2% identity with the coding sequence of Tuba1a, a gene that is highly expressed in the developing CNS.
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To establish whether the results reported by Sheridan and colleagues are a consequence of cross-hybridization, we conducted in situ hybridization on the developing (E14.5, E16.5, and P0) and adult mouse brain employing their probe and two others that we designed. We first confirmed the sequence of Tuba8 mRNA by amplifying
